Unspecified B-cell lymphoma
- C85.1 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- The 2025 edition of ICD-10-CM C85.1 became effective on October 1, 2024.
- This is the American ICD-10-CM version of C85.1 – other international versions of ICD-10 C85.1 may differ.
Note
- If B-cell lineage or involvement is mentioned in conjunction with a specific lymphoma, code to the more specific description.
The following code(s) above C85.1 contain annotation back-references
that may be applicable to C85.1:
- C00-D49 Neoplasms
- C81-C96 Malignant neoplasms of lymphoid, hematopoietic and related tissue
- C85 Other specified and unspecified types of non-Hodgkin lymphoma
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
- 2025 (effective 10/1/2024): No change
Code annotations containing back-references to C85.1:
- Type 1 Excludes: C88
Diagnosis Index entries containing back-references to C85.1: